Collections : RETINA

Secondary Logo

Journal Logo


Diabetic Macular Edema

  • Creator:   SCarrera
  • Updated:   8/22/2019
  • Contains:  17 items
From the Editor:

The objective of RETINA, The Journal of Retinal and Vitreous Diseases, is to keep its readership up-to-date on the advances in their field of interest. This includes not only clinically applicable developments but also those in the clinical and translational research arenas. This newsletter highlights recent articles from the Journal that scan these objectives. The treatment of diabetic macular edema is at hand. We now have multiple modalities to approach this devastating condition. Our challenge is not only to find the best treatments available today but to continue to develop new and even better treatments in the future.

All articles presented here are freely available for download. In addition to the below articles, do not miss the articles in press:

Age-Related Macular Degeneration

  • Updated:   8/22/2019
  • Contains:  14 items
From the Editor: We have come so far but yet we know so little. Our understanding of age-related macular degeneration (AMD) has evolved over the past 40 years from a condition which was almost guaranteed to cause blindness (although we as ophthalmologists used to assure our patients that “black” blindness would never occur) to a disease for which some degree of control is now possible. A cure is not yet in sight. We have gone from thermal lasers to photodynamic therapy. We have gone from photography to fluorescein angiography and indocyanine green angiography to multimodal imaging of the disease. Some of the articles provided address AMD, its diagnosis and its treatment. Primary care physicians, internists, and patients alike all asked the question of the relationship between cardiovascular disease and age-related macular degeneration. Yang, Wang, and others take a look at whether we any closer to finding that answer. Some suggest that there is a relationship between age-related macular degeneration and diabetic retinopathy, see article by Hahn, Acquah, and others. Computers and Medicare databases now allow us to ask those questions and seek answers. We should not forget the possible relationship of the vitreous and its proximity and physical attachment to the retina as discussed in the article by Jackson, Nicod, and others. In fact what is the effect of vitreous traction on age-related macular degeneration? Outer retinal tabulation has now been recognized as an important feature of macular degeneration and its clinical correlation has now been well demonstrated. The more advanced we become the more complicated our evaluation of patients has become. Multimodal imaging and multimodal vision testing in age-related macular degeneration has now become critically important and is discussed below in the article by Schaal, Freund, and coauthors. While the MPS stressed the importance of differentiating occult from classic choroidal neovascularization, modern technology has led many physicians to simply look at an OCT to determine if treatment is necessary. Perhaps it is time for us to use multimodal imaging such as fluorescein angiography, ICG angiography, and optical coherence tomography together to help us understand and differentiate type I choroidal neovascularization that occurs secondary to chronic central serous choroidopathy from neovasculariaztion secondary to age-related macular degeneration. Differentiating the cause for the choroidal neovascularization might lead us to a different treatment paradigm than treating all choroidal neovascularization the same way (see article by Fung, Yannuzzi, and Freund). All articles presented here are freely available for download.

Diabetic Retinopathy

  • Updated:   8/22/2019
  • Contains:  4 items
From the Editor: Diabetic retinopathy has not changed in its form since it was first identified. The presence of micro aneurysms, hemorrhages, cystoid macular edema and retinal neovascularization continue to complicate diagnosis and treatment. Although the diabetic retinopathy study (DRS), early treatment diabetic retinopathy study (ET DRS), diabetes control and complication trial (DC CT), and diabetic retinopathy clinical research network (DRCRnet) have greatly altered our approach to diabetic retinopathy, this systemic condition still poses a great challenge for all retinal specialists. The articles highlighted here provide an overview of the history of diabetic retinopathy and its management and how it has evolved over the last several decades. New technologies now suggest that we focus much of our interest on how we classify diabetic retinopathy using new techniques such as optical coherence tomography. Additionally, we are now beginning to appreciate that diabetes and diabetic retinopathy are not in a vacuum, and we are looking for associations with other conditions that may also affect the eye. A most enlightening editorial by Robert Frank, shown below, helps us to understand the possibility of such relationships. All articles presented here are freely available for download. In addition to the below articles, do not miss the article in press: “Evolution of Controlling Diabetic Retinopathy: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade”.

Retina Supplements

  • Creator:   S Carrera
  • Updated:   8/22/2019
  • Contains:  7 items
Supplements from the journal Retina


  • Creator:   Shelley Withers
  • Updated:   11/4/2022
  • Contains:  35 items
March 2020 - Volume 40 - 3